Reset filter
Palabras clave
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
    1. 7.1. Anestesiología
    1. 7.2. Dermatología
    1. 7.3. ENT
    1. 7.4. Geriatría
    1. 7.5. Ginecología / Obstetricia
    1. 7.6. Medicina Interna
      1. Hematología
      1. Enfermedades infecciosas
      1. Cardiología / Angiología
      1. Neumología
      1. Gastroenterología
      1. Nefrología
      1. Endocrinología / Enfermedades metabólicas
      1. Reumatología
    1. 7.7. Neurología
    1. 7.8. Oftalmología
    1. 7.9. Cuidados paliativos
    1. 7.10. Patología / Forense
    1. 7.11. Pediatría
    1. 7.12. Psiquiatría / Psicosomática
    1. 7.13. Radiología
    1. 7.14. Cirugía
      1. Cirugía General / Visceral
      1. Neurocirugía
      1. Cirugía plástica
      1. Cirugía Torácica
      1. Traumatología / Ortopedia
      1. Cirugía vascular
    1. 7.15. Urología
    1. 7.16. Odontología / OMS
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

2006 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Pathology - Colon and Rectum Carcinoma - Anatomic Pathology Form - 2019345v2.31 - Colon and Rectum Carcinoma - Anatomic Pathology Form

- 8/1/15 - 1 formulario, 4 itemgroups, 65 items, 1 idioma
Itemgroups: COLORECTAL: CRF HEADER , COLORECTAL PATHOLOGY: FORM ADMINISTRATION, PATHOLOGY: SURGICAL PATHOLOGY - MACROSCOPIC/GROSS DESCRIPTION, PATHOLOGY: SURGICAL PATHOLOGY - MICROSCOPIC DESCRIPTION
Colon and Rectum Carcinoma - Anatomic Pathology Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A97A-3FA4-E034-080020C9C0E0

Eligibility Postoperative Ileus NCT02510911

- 14/6/19 - 1 formulario, 2 itemgroups, 20 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?; ODM derived from: https://clinicaltrials.gov/show/NCT02510911

Eligibility Colon Endoscopy DRKS00006283 NCT02182466 DRKS00006283 - Eligibility Colon Endoscopy NCT02182466 DRKS00006283

- 4/7/17 - 1 formulario, 2 itemgroups, 7 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Responsible Party: Jorg Albert, [Dokumentation von Kolonkapsel-Endoskopien im Rahmen einer bundesweiten Studie], Johann Wolfgang Goethe University Hospitals ClinicalTrials.gov Identifier: NCT02182466 History of Changes Other Study ID Numbers: 265/13 DRKS-ID: DRKS00006283 ( Other Identifier: German Clinical Trials Registry ) Study First Received: June 27, 2014 Last Updated: July 2, 2014 German Colon Capsule Registry (DEKOR) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02182466

Eligibility Colon Cancer NCT00819780

- 20/12/17 - 1 formulario, 2 itemgroups, 16 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00819780

Eligibility Colon Cancer NCT01003600

- 20/12/17 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information; ODM derived from: https://clinicaltrials.gov/show/NCT01003600

Eligibility Colon Cancer NCT00890188

- 20/12/17 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00890188

Eligibility Colon Cancer NCT00411450

- 10/2/17 - 1 formulario, 2 itemgroups, 18 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00411450

Eligibility Liver Metastasis NCT00068068

- 8/10/16 - 1 formulario, 2 itemgroups, 21 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00068068

Eligibility Colon Cancer NCT00695201

- 10/1/16 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00695201

Eligibility Liver Cirrhosis NCT02508623

- 27/4/19 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices; ODM derived from: https://clinicaltrials.gov/show/NCT02508623

E5202 Colon Cancer On-Study Form NCT00217737

- 8/7/15 - 1 formulario, 9 itemgroups, 33 items, 1 idioma
Itemgroups: Header, Patient demographics, Data amendment, Baseline Evaluation, Pathologic Staging, CEA, Disease Description, Biological Markers, Comments
E5202 Colon Cancer On-Study Form NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF21AC34-1C36-1B9F-E034-0003BA3F9857

NCT00096278 NSABP PROTOCOL C-08: LIVER FUNCTION TEST FOLLOW-UP FORM

- 3/7/15 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Header, Liver function
NCT00096278 NSABP PROTOCOL C-08: LIVER FUNCTION TEST FOLLOW-UP FORM Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF5136E1-073F-1BFA-E034-0003BA3F9857

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial